Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Upgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Spiderwort

Spiderwort

A biotechnology company using tissue engineering to create biomaterials for repairing and regenerating the human body.

OverviewStructured DataIssuesContributorsActivity
Contents

Spiderwort is a biotechnology company using tissue engineering to create biomaterials for repairing and regenerating the human body that is headquartered in Ottawa, Ontario and was founded in 2015 by Andrew Pelling and Charles M. Cuerrier. The company is using plant derived cellulose to create biomaterial scaffolding architectures that are biocompatible and capable of inducing angiogenesis (blood vessel generation), promote cell infiltration, promote cell growth, promote tissue repair, and promote tissue reconstruction.

Funding
Angel

On June 10, 2019 Spiderwort announced raising CA$500,000 from the CEO of Assent Compliance Andrew Waitman. At the time of announcing their angel funding round the company also announced Dane Bedward, an executive fellow with Mistral Ventures Partners, and Peter Morand, former CEO and president of Natural Sciences and Engineering Research Council of Canada and the founding CEO of the Canadian Science and Technology Growth Fund, will be joining the company's board of directors.

Seed

On May 27, 2020 Spiderwort announced raising $2.5 million in seed funding from Horizons Ventures (lead investors), Capital Angel Network, Break Off Capital, and Anges Quebec. The company plans on using their seed funding to develop a treatment for spinal cord injuries using plant-based materials. Spiderwort also named Dane Benward, the former president of Genzyme Canada and executive fellow of Mistral Venture Partners, the chairman of Spiderworts board of directors. Patrick Zhang from Horizons Ventures also joined the board of Spiderwort at the time of seed funding.

Timeline

May 27, 2020
Seed

On May 27, 2020 Spiderwort announced raising $2.5 million in seed funding from Horizons Ventures (lead investors), Capital Angel Network, Break Off Capital, and Anges Quebec.

June 10, 2019
Angel funding

On June 10, 2019 Spiderwort announced raising CA$500,000 from the CEO of Assent Compliance Andrew Waitman.

2015
Founding of Spiderwort

Funding Rounds

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

spiderwortbio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
Ottawa
Ottawa
Gatineau
Gatineau
CEO
‌
Charles M. Cuerrier
Founder
‌
Charles M. Cuerrier
‌
Andrew E. Pelling
Full Address
7 Bayview Road, Ottawa, Ontario K1Y 2C5, CA
283, boulevard Alexandre-Taché (F3006) Gatineau, Québec J9A 1L8
Investors
Groupe Roski
Groupe Roski
Horizons Ventures
Horizons Ventures
K5 Global
K5 Global
BoxOne Ventures
BoxOne Ventures
Box One Ventures
Box One Ventures
Founded Date
2015
Total Funding Amount (USD)
13,200,000
CFO
‌
Scott Jarvis
Latest Funding Type
Series A round
Series A round
Wellfound ID
spiderwort

Other attributes

Company Operating Status
Active
Country
Canada
Canada
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocol
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.